April 16, 2024
TOPLINE: Continuous glucose monitoring (CGM) data provide a more comprehensive characterization of glucose values than fasting glucose (FG) measurement alone. Considerable FG variability was seen even […]
April 16, 2024
Budapest, Hungary — Electroconvulsive therapy (ECT) dramatically improves disease severity and depressive symptoms in patients with severe mental illness, results of a large, naturalistic study showed. […]
April 16, 2024
Guidance Snapshots are a communication tool that provide highlights from guidance documents using visuals and plain language to support transparent communication and dissemination of FDA guidance […]
April 16, 2024
ATLANTA, GA — A multicenter controlled trial testing the ability of an aldose reductase inhibitor to stabilize early-stage asymptomatic diabetic cardiomyopathy missed its primary endpoint, researchers […]
April 16, 2024
BALTIMORE — Patients who have complications after dermatologic cosmetic procedures are prone to high rates of a host of mental health issues, ranging from anxiety disorder […]
April 16, 2024
Recent cases of botulism-like illness following neurotoxin injections in nonmedical settings have prompted the American Society for Dermatologic Surgery Association (ASDSA) to call on states to […]
April 16, 2024
TOPLINE: Botulinum toxin (BTX) and dermal fillers are safe as cosmetic and antiaging treatments in individuals with skin of color (SOC), with the largest amount of […]
April 16, 2024
Four years ago in the spring of 2020, physicians and patients coined the term “long COVID” to describe a form of the viral infection from which […]
April 16, 2024
The photo of the patient’s foot, sent from his campsite, included a cheeky note: “I remember you telling me that getting in trouble doing something was […]